About ILLUMINATE

About the Studies

The ILLUMINATE-101 Study is looking to compare the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten compared to placebo in those with celiac disease who are on a gluten-free diet. We will be evaluating to see how well the investigational medication improves tolerance to gluten by avoiding the body’s negative responses to gluten exposure. The study medication (investigational or placebo) will be given to participants 3 times via IV infusion. The study has up to 10 clinic visits* and 1 follow-up phone call, and total study duration per participant is up to 34 weeks.

The ILLUMINATE-062 Study is looking at the safety and effectiveness of an investigational medication designed to break down gluten in the stomach compared with placebo in those with celiac disease who are on a gluten-free diet. The study will evaluate how well the investigational medication reduces celiac-related symptoms and intestinal damage due to gluten exposure. The study medication (investigational or placebo) is an oral pill that should be taken 3 times per day within 15 minutes of the start of a meal. The study has about 7 clinical visits* and total study duration per participant is up to 36 weeks.

You will need to consume small amounts of gluten during these studies. More information on this requirement will be available for those that pre-qualify.

*Some visits may be performed at home

Please consider enrolling in these studies today.

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.